Cases & Deals

  • Home
  • Practices
  • Gimv sells majority stake in outpatient rehabilitation specialist rehaneo to Fremman Capital

Share

Gimv sells majority stake in outpatient rehabilitation specialist rehaneo to Fremman Capital

November 2024

Client(s) Gimv N.V.

Jones Day is advising Gimv NV, the pan-European PE fund, in the sale of its majority stake in outpatient rehabilitation specialist, rehaneo, to Fremman Capital. To date, rehaneo has integrated 13 companies at 23 locations nationwide into the group, including some of the leading facilities in Germany. Recently, rehaneo also opened a completely new center in Göttingen.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.